Part 2 audit sponsor eligibility

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

The sponsor must fit a named route

42 CFR 2.53 describes who may sponsor an audit or evaluation in the no-copy and copied-record pathways. Record the legal entity, role, funding, regulatory authority, covered population, contract, delegation, administrative control, or qualifying relationship that supports the engagement.

Start with the exact paragraph and actor rather than a broad label. Preserve agency authority, grant or financial-assistance record, health-plan or payer relationship to the relevant patients, QIO status, direct administrative-control evidence, or qualifying delegation. Match legal names, effective dates, programs, products, populations, and scope.

Government affiliation alone may not show that the agency regulates or funds the program or lawful holder for this review. A payer contract may apply to some patients or products and not others. A parent, affiliate, investor, management company, or network may lack the direct administrative-control relationship needed for the proposed route.

Match the sponsor to data and purpose

Define the audit question, program, patient population, services, claims or records, date range, reviewer, and expected output. Compare them with the sponsor's actual relationship. A payer should not receive records for people it does not cover under a broad provider audit, and a funder should not use the route for an unrelated commercial study.

Minimize the cohort and fields to the supported relationship. Keep counseling notes, unrelated episodes, family detail, other payer data, free text, and patient contact information restricted unless specifically justified.

Sponsor and purpose are separate gates

An eligible sponsor still needs a qualifying audit or evaluation purpose, an appropriate reviewer, written commitments, controlled access, and applicable security and retention terms. Confirm data movement and downstream-use rules before release.

Choose the no-copy or copied-record pathway from the real data flow. Obtain the required written terms, verify reviewer identity and competence, secure the environment, control outputs, and document closure. Sponsor eligibility does not authorize research, marketing, litigation, employment, general analytics, or law-enforcement use.

Reassess changes and close engagements

Pause access on contract expiration, coverage change, loss of authority, merger, sponsor substitution, assignment change, new purpose, broader population, or new data movement. Do not let a prior eligible relationship support a later unrelated project.

At completion, disable accounts, reconcile copies and outputs, apply retention and destruction, and retain sponsor evidence. If an unsupported sponsor received access, contain it, preserve evidence, and route privacy, security, audit, payer, legal, clinical, and patient communication decisions.

Example with proposed sponsors

Fourteen engagements are classified. Eleven have evidence of a named sponsor relationship; three use unsupported consulting or affiliate labels. Sponsor readiness is 11 of 14 engagements.

One consultant obtains a valid delegation from the eligible payer and narrows the cohort. A second affiliate documents direct administrative control. The third remains held because its analytics purpose is unrelated to the funding relationship. All original classifications remain visible.

Sponsor-eligibility checklist

• Identify the exact sponsor category and supporting paragraph.
• Preserve authority, funding, coverage, QIO, control, or delegation evidence.
• Match legal entity, program, population, product, dates, and purpose.
• Trace contractors, subcontractors, and representatives to the principal.
• Minimize records to the supported relationship and question.
• Apply reviewer, agreement, data-flow, security, and closure gates separately.
• Pause changed relationships and investigate unsupported access.

Owner controls

The 2024 final rule provides current context. Use sponsor categories, authority records, contracts, delegation chains, patient-coverage evidence where relevant, change triggers, legal review, and engagement closure.

Monitor sponsor types, evidence age, delegations, subcontractors, populations, data fields, relationship changes, access expiry, and incidents. Audit from each review back to an eligible sponsor and from active sponsor accounts into current contracts and covered cohorts. Retest after payer, funding, regulatory, ownership, vendor, or organizational changes.